Ibuprofen plus isosorbide dinitrate treatment in the mdx mice ameliorates dystrophic heart structure-Reference-Cited by-同舟云学术

Ibuprofen plus isosorbide dinitrate treatment in the mdx mice ameliorates dystrophic heart structure

Published:2013-07 Issue: Volume:73 Page:35-43
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Sciorati Clara,Staszewsky Lidia,Zambelli Vanessa,Russo Ilaria,Salio Monica,Novelli Deborah,Di Grigoli Giuseppe,Moresco Rosa Maria,Clementi Emilio,Latini Roberto

Funder

European Community's framework programme FP7/2007-2013

Italian Ministry of Health RC 2012

Associazione Italiana Ricerca sul Cancro (AIRC IG11362)

Parent Project Italia

Fondazione CARIPLO “Ricerca Scientifica e Trasferimento Tecnologico

Publisher

Elsevier BV

Subject

Pharmacology

Reference58 articles.

1. The muscular dystrophies;Emery;Lancet,2002

2. The heart in human dystrophinopathies;Finstererand;Cardiology,2003

3. Echocardiographic evaluation of fibrous replacement in the myocardium of patients with Duchenne muscular dystrophy;Miyoshi;British Heart Journal,1991

4. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy;Nigro;International Journal of Cardiology,1990

5. 107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th–9th June 2002, Naarden, the Netherlands

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of the Cardiac Structure and Function of Conscious D2.B10-Dmdmdx/J (D2-mdx) mice from 16–17 to 24–25 Weeks of Age;International Journal of Molecular Sciences;2023-07-22

2. Key concepts in muscle regeneration: muscle “cellular ecology” integrates a gestalt of cellular cross-talk, motility, and activity to remodel structure and restore function;European Journal of Applied Physiology;2021-12-20

3. Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model;BMC Cardiovascular Disorders;2021-06-15

4. EPR-Effect Enhancers Strongly Potentiate Tumor-Targeted Delivery of Nanomedicines to Advanced Cancers: Further Extension to Enhancement of the Therapeutic Effect;Journal of Personalized Medicine;2021-05-28

5. Role of the Renin–Angiotensin–Aldosterone System in Dystrophin-Deficient Cardiomyopathy;International Journal of Molecular Sciences;2020-12-31